09:21 AM EDT, 05/18/2026 (MT Newswires) -- Emergent BioSolutions (EBS) said Monday the Saudi Food and Drug Authority has approved the registration of its smallpox and mpox vaccine, ACAM2000.

"Smallpox is considered a credible bioterror threat by experts, and its mortality makes it a potential high-impact threat with health, economic, and national security implications,"the company said in a statement.

Shares of Emergent BioSolutions were up close to 4% pre-bell.

Ämnen i artikeln

Emergent BioSolutions

Senast

8,24

1 dag %

3,78%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån